sclc hyperprogression with nivolumab
Published 4 years ago • 183 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:18
checkpoint inhibitors in small cell lung cancer (sclc)
-
4:04
hyperprogressive disease in lung cancer
-
2:31
transformed sclc: emerging science on histologic subtype switching
-
0:55
the potential of targeted and immune therapies in sclc
-
0:38
addressing treatment strategies for limited stage small cell lung cancer
-
5:43
novel immunotherapy combinations for sclc
-
0:51
challenges associated with implementing immune checkpoint blockade in sclc
-
2:33
concurrent immunotherapy in sclc
-
4:41
new screening and therapy strategies for sclc
-
1:14
dr. kim addresses concerns about hyperprogression in nsclc
-
1:30
dr. feliciano on nivolumab in small cell lung cancer
-
2:27
dr. chiang discusses ipilimumab/nivolumab combo in small cell lung cancer
-
2:21
emerging frontline strategies in es-sclc
-
1:02
dr. hellmann on nivolumab in combination with ipilimumab for small cell lung cancer
-
37:51
hyperprogressive disease in nsclc
-
0:59
immune checkpoint inhibitors: recent progress and potential biomarkers - 2iii immune cells
-
2:01
chemoimmunotherapy, the uk & extensive-stage sclc
-
5:06
impower133 in sclc
-
6:13
checkmate-227: testing ipilimumab/nivolumab in nsclc